Recent scRNA sequencing studies have suggested that IL‐36γ and IL‐36Ra are expressed at higher levels in epithelial cells than in other types of cells from tumors of CRC patients,[33] indicating that immune cells are not a primary source of IL‐36γ and IL‐36Ra in colon tumors. This evidence concerns the gene IL36G and colorectal carcinoma.